The first part of our 2025 annual meeting will focus on the biological diagnosis of Parkinson’s disease and explore potential upcoming disease-modifying therapies.
In the second part, attention will shift to Ataxia, covering the clinical approach to patients as well as genetic and acquired forms of the condition.
For both topics, we are happy to welcome distinguished national and international experts as speakers.
